ReviewEuropean journal of nuclear medicine and molecular imaging2022

Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond.

Mengting Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.